PCR is the standard for measuring DNA from ChIP because of its ability to simultaneously amplify and detect from limited samples. Compared to end‐point PCR, real‐time PCR (qPCR) provides faster data acquisition, greater dynamic range and increased sensitivity. However, the traditional “targeted” assay design scheme (primers flanking a binding site) hinders the design of amplicons meeting the performance criteria of specificity and amplification efficiency. To avoid this issue, we have applied an alternative “tiling” assay design scheme that allows greater flexibility in positioning the primers away from poor PCR sequences. Using this approach on a genome‐wide scale, 30 kb regions of promoters have been successfully “tiled” at a 1 kb interval with assays that display consistent, high‐quality qPCR performance. When used to measure p53 binding interactions in the CDKN1A promoter of HCT116 cells after treatment with 5‐FU, the ChIP‐qPCR assays showed that p53 binding increased from a few fold to 50 fold above background. Tiling assays corresponding to p53 binding sites in other genes show similar enrichments. The functional consequences of the p53 binding was also confirmed by RT‐qPCR measurement of mRNA. The genome‐wide availability of promoter tiling ChIP‐qPCR assays allows an increased number of binding sites to be surveyed simultaneously and facilitates ChIP‐chip microarray validation.